Fidelity Investments’s Centessa Pharmaceuticals CNTA Stock Holding History

Fidelity Investments’s Portfolio CNTA Stock Details CNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$272M	Sell	6,852,047 -2,109,892	-24%	-$54M	0.01%	726
2025 Q4	$224M	Buy	8,961,939 +2,684,696	+43%	+$68M	0.01%	822
2025 Q3	$152M	Buy	6,277,243 +2,451,049	+64%	+$43.6M	0.01%	972
2025 Q2	$50.3M	Hold	3,826,194	–	–	﹤0.01%	1396
2025 Q1	$55M	Buy	3,826,194 +174,600	+5%	+$2.86M	﹤0.01%	1320
2024 Q4	$61.2M	Buy	3,651,594 +735,100	+25%	+$12.2M	﹤0.01%	1308
2024 Q3	$46.6M	Buy	2,916,494 +129,300	+5%	+$1.58M	﹤0.01%	1410
2024 Q2	$25.2M	Hold	2,787,194	–	–	﹤0.01%	1567
2024 Q1	$31.5M	Hold	2,787,194	–	–	﹤0.01%	1500
2023 Q4	$22.2M	Hold	2,787,194	–	–	﹤0.01%	1589
2023 Q3	$18M	Hold	2,787,194	–	–	﹤0.01%	1622
2023 Q2	$17.3M	Buy	2,787,194 +1,556,285	+126%	+$7.38M	﹤0.01%	1702
2023 Q1	$4.74M	Hold	1,230,909	–	–	﹤0.01%	2113
2022 Q4	$3.82M	Buy	1,230,909 +522,118	+74%	+$1.94M	﹤0.01%	2192
2022 Q3	$2.85M	Buy	708,791 +698,491	+6,781%	+$3.19M	﹤0.01%	2336
2022 Q2	$50K	Hold	10,300	–	–	﹤0.01%	3565
2022 Q1	$92K	Sell	10,300 -84,000	-89%	-$766K	﹤0.01%	3477
2021 Q4	$1.06M	Sell	94,300 -268,437	-74%	-$3.61M	﹤0.01%	2678
2021 Q3	$6.06M	Sell	362,737 -427,263	-54%	-$8.84M	﹤0.01%	2302
2021 Q2	$17.5M	Buy	+790,000	New	+$18.6M	﹤0.01%	1893

Other funds holding CNTA

MVM

Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

IVLAV

Index Venture Life Associates VI St. Helier, Jersey $396M AUM 176.22% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Fidelity Investments's CNTA Position: Q1 2026 in Review

Fidelity Investments reduced its Centessa Pharmaceuticals (CNTA) stake by 24% in Q1 2026, selling an estimated $54M and leaving 6,852,047 shares worth $272M. The position accounts for 0.01% of the portfolio, ranked #726.

Fidelity Investments first reported a position in CNTA in Q2 2021 and has held it in 20 quarters since. 161 funds tracked by Wall St. Rank hold CNTA as of Q1 2026.

Fidelity Investments held 6,852,047 shares of Centessa Pharmaceuticals worth $272M as of Q1 2026.
Fidelity Investments sold 2,109,892 Centessa Pharmaceuticals shares in Q1 2026, an estimated $54M.
Centessa Pharmaceuticals made up 0.01% of Fidelity Investments's portfolio in Q1 2026, its #726 holding.
Fidelity Investments first reported a position in Centessa Pharmaceuticals in Q2 2021 and has held it in 20 quarters since.
161 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q1 2026.

Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.